New Analysis Reveals F.D.A. Decisions on Abortion Pill Were Based on Science

A group of healthcare professionals discusses the implications of recent F.D.A. analyses on the abortion pill during a conference focused on reproductive rights.

In 2000, the F.D.A. approved mifepristone, a medication used in combination with another drug, misoprostol, to terminate early pregnancies. Over the years, the approval process and subsequent regulatory changes have been scrutinized, particularly by anti-abortion advocates. However, the new analysis underscores that the agency’s decisions were based on extensive research and clinical data supporting the … Read more